2.4. Data Collection and Scale Scoring
Stroke, stroke, TG, infarct, diabetes
STROKE, HYPERLIPIDEMIA, STROKE, PLAQUE, HYPERTENSION, INFARCT, DIABETES
Demographic and clinical statistics including age, BMI, sex, smoke condition, diastolic blood pressure (DBP), systolic blood pressure (SBP) and history of hypertension, hyperlipidemia, and diabetes were collected. Using an automatic biochemical analyzer to performed whole blood test by Hitachi 7600 of Hitachi Corporation, the total cholesterol (TC), fasting plasma glucose (FPG), triglyceride (TG), low-density leptin cholesterol (LDLC), and high-density leptin cholesterol (HDLC) levels were recorded. Imaging indexes of MRI and CT including infarct location, infarct volume, multiple or single, and vulnerable plaque were collected. The National Institutes of Health Stroke Scores (NIHSS) were recorded when the subjects were hospitalized to assess the severity of stroke. Using the modified Rankin Scale (mRS) to assess the prognosis after 90 days of treatment, mRS score ≥ 3 indicated a bad prognosis, and mRS score ≤ 2 indicated a good prognosis.